Inhibition of Src Kinase Blocks High Glucose–Induced EGFR Transactivation and Collagen Synthesis in Mesangial Cells and Prevents Diabetic Nephropathy in Mice

Chronic exposure to high glucose leads to diabetic nephropathy characterized by increased mesangial matrix protein (e.g., collagen) accumulation. Altered cell signaling and gene expression accompanied by oxidative stress have been documented. The contribution of the tyrosine kinase, c-Src (Src), which is sensitive to oxidative stress, was examined. Cultured rat mesangial cells were exposed to high glucose (25 mmol/L) in the presence and absence of Src inhibitors (PP2, SU6656), Src small interfering RNA (siRNA), and the tumor necrosis factor-α–converting enzyme (TACE) inhibitor, TAPI-2. Src was investigated in vivo by administration of PP2 to streptozotocin (STZ)-induced diabetic DBA2/J mice. High glucose stimulated Src, TACE, epidermal growth factor receptor (EGFR), mitogen-activated protein kinases (MAPKs), extracellular signal–regulated kinase (ERK1/2, p38), and collagen IV accumulation in mesangial cells. PP2 and SU6656 blocked high glucose–stimulated phosphorylation of Src Tyr-416, EGFR, and MAPKs. These inhibitors and Src knockdown by siRNA, as well as TAPI-2, also abrogated high glucose–induced phosphorylation of these targets and collagen IV accumulation. In STZ-diabetic mice, albuminuria, increased Src pTyr-416, TACE activation, ERK and EGFR phosphorylation, glomerular collagen accumulation, and podocyte loss were inhibited by PP2. These data indicate a role for Src in a high glucose-Src-TACE-heparin-binding epidermal growth factor-EGFR-MAPK–signaling pathway to collagen accumulation. Thus, Src may provide a novel therapeutic target for diabetic nephropathy.

[1]  A. Ergul,et al.  Endothelin antagonism prevents early EGFR transactivation but not increased matrix metalloproteinase activity in diabetes. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[2]  Shunqiang Li,et al.  Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach , 2005, Nature Medicine.

[3]  J. Douglas,et al.  Arachidonic acid induces ERK activation via Src SH2 domain association with the epidermal growth factor receptor. , 2006, Kidney international.

[4]  M. Mauer,et al.  The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007 , 2008, Diabetologia.

[5]  S. Courtneidge,et al.  The interplay between Src family kinases and receptor tyrosine kinases , 2004, Oncogene.

[6]  T. Kita,et al.  Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy , 2006, Laboratory Investigation.

[7]  D. Stewart,et al.  Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. , 2002, The Journal of clinical investigation.

[8]  M. Moasser,et al.  The epidermal growth factor receptor family: Biology driving targeted therapeutics , 2008, Cellular and Molecular Life Sciences.

[9]  M. Kretzler,et al.  From Fibrosis to Sclerosis , 2008, Diabetes.

[10]  K. Ramana,et al.  Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells. , 2009, Endocrinology.

[11]  Samy Suissa,et al.  Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.

[12]  P. Fioretto,et al.  The Kidney in Diabetes: Dynamic Pathways of Injury and Repair , 2007 .

[13]  P. Johnston,et al.  Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAIL. , 2008, Cancer research.

[14]  Hong Wang,et al.  Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression. , 2006, American journal of physiology. Renal physiology.

[15]  Jia Yin,et al.  ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. , 2009, Investigative ophthalmology & visual science.

[16]  G. Striker,et al.  Glomerular type IV collagen in patients with diabetic nephropathy with and without additional glomerular disease. , 2000, Kidney international.

[17]  C. Betsholtz,et al.  A new method for large scale isolation of kidney glomeruli from mice. , 2002, The American journal of pathology.

[18]  A. Nishiyama,et al.  BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions. , 2004, Kidney international.

[19]  P. Xie,et al.  Diabetic Nephropathy: Mechanisms of Renal Disease Progression , 2008, Experimental biology and medicine.

[20]  A. Ullrich,et al.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.

[21]  M. Bissell,et al.  Targeting TACE-dependent EGFR ligand shedding in breast cancer. , 2007, The Journal of clinical investigation.

[22]  Y. Mori,et al.  Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells. , 2001, Kidney international.

[23]  C. Alpers,et al.  Mouse models of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  M. Haneda,et al.  Overview of glucose signaling in mesangial cells in diabetic nephropathy. , 2003, Journal of the American Society of Nephrology : JASN.

[25]  M. Soellner,et al.  Development of a highly selective c-Src kinase inhibitor. , 2012, ACS chemical biology.

[26]  D. Threadgill,et al.  EGFR signaling promotes TGFβ-dependent renal fibrosis. , 2012, Journal of the American Society of Nephrology : JASN.

[27]  Craig E. Higgins,et al.  TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling. , 2008, Journal of molecular and cellular cardiology.

[28]  A. Eid,et al.  Nox4 NAD(P)H Oxidase Mediates Src-dependent Tyrosine Phosphorylation of PDK-1 in Response to Angiotensin II , 2008, Journal of Biological Chemistry.

[29]  D. Lawrence,et al.  A PAI-1 mutant, PAI-1R, slows progression of diabetic nephropathy. , 2008, Journal of the American Society of Nephrology : JASN.

[30]  N. Wahab,et al.  J Am Soc Nephrol 14: 1358–1373, 2003 Extracellular Matrix Metabolism in Diabetic Nephropathy , 2022 .

[31]  A. Ullrich,et al.  Distinct ADAM Metalloproteinases Regulate G Protein-coupled Receptor-induced Cell Proliferation and Survival* , 2004, Journal of Biological Chemistry.

[32]  J. Siegfried,et al.  Src Family Kinases Mediate Epidermal Growth Factor Receptor Ligand Cleavage, Proliferation, and Invasion of Head and Neck Cancer Cells , 2004, Cancer Research.

[33]  Ling Zhu,et al.  TGF-beta-regulated collagen type I accumulation: role of Src-based signals. , 2007, American journal of physiology. Cell physiology.

[34]  Y. Mori,et al.  Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells. , 2002, Kidney international.

[35]  M. Maa,et al.  c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function* , 1999, The Journal of Biological Chemistry.

[36]  T. Kita,et al.  Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy , 2006, Laboratory Investigation.

[37]  G. Bokoch,et al.  The involvement of the tyrosine kinase c-Src in the regulation of reactive oxygen species generation mediated by NADPH oxidase-1. , 2008, Molecular biology of the cell.

[38]  Ling Zhu,et al.  TGF-β-regulated collagen type I accumulation: role of Src-based signals , 2007 .

[39]  Eva Klinman,et al.  Ectodomain cleavage of the EGF ligands HB‐EGF, neuregulin1‐β, and TGF‐α is specifically triggered by different stimuli and involves different PKC isoenzymes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  B. H. Shah,et al.  Roles of Src and Epidermal Growth Factor Receptor Transactivation in Transient and Sustained ERK1/2 Responses to Gonadotropin-releasing Hormone Receptor Activation* , 2003, Journal of Biological Chemistry.

[41]  L. Luttrell,et al.  5-HT2A Receptor Induces ERK Phosphorylation and Proliferation through ADAM-17 Tumor Necrosis Factor-α-converting Enzyme (TACE) Activation and Heparin-bound Epidermal Growth Factor-like Growth Factor (HB-EGF) Shedding in Mesangial Cells* , 2006, Journal of Biological Chemistry.

[42]  H. Wiley,et al.  Multiple Mechanisms Are Responsible for Transactivation of the Epidermal Growth Factor Receptor in Mammary Epithelial Cells* , 2008, Journal of Biological Chemistry.

[43]  Timothy J. Yeatman,et al.  A renaissance for SRC , 2004, Nature Reviews Cancer.

[44]  Carlos L. Arteaga,et al.  Transforming Growth Factor (cid:2) Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab (cid:1) † , 2008 .

[45]  Weina Yang,et al.  Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats. , 2012, Cytokine.

[46]  J. Krepinsky,et al.  Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells , 2007, Diabetologia.

[47]  M G Natchus,et al.  Discovery of potent, achiral matrix metalloproteinase inhibitors. , 1998, Journal of medicinal chemistry.

[48]  G. Mills,et al.  Phosphorylation of TNF-alpha converting enzyme by gastrin-releasing peptide induces amphiregulin release and EGF receptor activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[49]  S. Kumar,et al.  HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells. , 2011, American journal of physiology. Renal physiology.

[50]  J. Hanke,et al.  Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor , 1996, The Journal of Biological Chemistry.

[51]  M. Gishizky,et al.  SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling , 2000, Molecular and Cellular Biology.

[52]  M. Breyer Stacking the deck for drug discovery in diabetic nephropathy: in search of an animal model. , 2008, Journal of the American Society of Nephrology : JASN.

[53]  G. Amorino,et al.  Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway , 2007, Oncogene.

[54]  G. Weskamp,et al.  Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands , 2004, The Journal of cell biology.

[55]  J. Padbury,et al.  A Novel Phosphoinositide 3-Kinase-dependent Pathway for Angiotensin II/AT-1 Receptor-mediated Induction of Collagen Synthesis in MES-13 Mesangial Cells* , 2007, Journal of Biological Chemistry.